Abstract
Exosomal MicroRNA-21 (miRNA-21, miR-21) is significantly up-regulated in blood samples of patients with lung cancer. Exosomal-derived miR-21 can be used as a promising biomarker for the early diagnosis of lung cancer. This paper develops a fluorescent biosensor based on the combination of magnetic nanoparticles (MNPs), cascade strand displacement reaction (CSDR) and CRISPR/Cas12a to detect the exosomal miR-21 from lung cancer. The powerful separation performance of MNPs can eliminate the potential interference of matrix and reduce the background signal, which is very beneficial for the improvement of specificity and sensitivity. The CSDR can specifically transform one miR-21 into plenty of DNA which can specifically trigger the trans-cleavage nuclease activity of Cas12a, resulting in the cleavage of ssDNA bi-labeled with fluorescent and a quencher. Under the optimized experimental conditions, the developed fluorescence biosensor exhibited high sensitivity and specificity towards the determination of exosomal-derived miR-21 with a linear range from 10 to 1 × 105 fM and a low detection limit of about 0.89 fM. Most importantly, this method can be successfully applied to distinguish the exosomal miR-21 from the lung cancer patients and the healthy people.
Funding Information
  • Sanming Project of Medicine in Shenzen Municipality (SZZYSM202106004)
  • Bao’an TCM Development Foundation (2020KJCX-KTYJ-200)
  • National Natural Science Foundation of China (81872509)
  • cientific research project of Guangdong Provincial Bureau of traditional Chinese Medicine (20221336)
  • Project of Guangdong provincial clinical drug research fund (special fund for pain relief in surgery, pharmacy and orthopaedics) (2021ZT11)
  • Youth Talent Project of Sinopharm Dongfeng General Hospital (2021Q03, 2022Q27)
  • Joint Funds for the Innovation of Science and Technology, Fujian province (2020Y9054)

This publication has 36 references indexed in Scilit: